Tuesday, November 05, 2013 8:36:49 AM
NEW YORK, Nov. 4, 2013 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) announced today that management will host a conference call and simultaneous webcast to provide a quarterly business update at 5:00 P.M. ET on Wednesday, November 6, 2013.
Participants should call (877) 377-7550 (United States/Canada) or (678) 224-7859 (International) and request the SIGA call or provide confirmation code 96658993. A live broadcast of the call will be available on the Company's website at www.SIGA.com under the 'Events & Presentations' tab in the Investor Relations section.
A replay of the call will be available approximately two hours after the call and will be accessible until 11:59 P.M. ET on November 20, 2013. To listen to the replay, dial (855) 859-2056 (Domestic) or (404) 537-3406 (International) and enter the code 96658993. The webcast of the event will also be archived on the Company's website for two weeks under the 'Events & Presentations' tab in the Investor Relations section.
About SIGA Technologies, Inc.
In the United States and around the globe, populations face a serious but unmet need for new drugs to protect against potentially catastrophic emerging viral pathogens and biological weapons of mass destruction. We are a pharmaceutical company specializing in discovering and developing pharmaceutical solutions for some of the most lethal pathogens — smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. Our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats. Our mission is to disarm dreaded viral diseases and create robust, modern biodefense countermeasures. For more information about SIGA, please visit SIGA's web site at www.siga.com.
Contact:
KCSA Strategic Communications
Todd Fromer / Rob Fink
212-896-1215 / 1206
tfromer@kcsa.com / rfink@kcsa.com
Recent SIGA News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:07:46 PM
- SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX® • GlobeNewswire Inc. • 08/21/2024 08:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 11:40:18 AM
- Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox Released • GlobeNewswire Inc. • 08/15/2024 11:35:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:59:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:06:09 PM
- SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024 • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/25/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 12:05:49 PM
- SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX® • GlobeNewswire Inc. • 07/19/2024 12:00:00 PM
- SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States • GlobeNewswire Inc. • 06/17/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:28:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:21:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:18:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:16:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:13:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:11:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:08:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:05:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:58:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:06:24 PM
- SIGA Reports Financial Results for Three Months Ended March 31, 2024 • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/01/2024 09:00:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM